www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
amounted to THB 231.1 million, a decrease of THB 178.7 million or 43.6% from the last year. The main factor causing the operating results in 2020 to change more than 20% from the last year was higher Profit
the year period ended December 31, 2019 To: President The Stock Exchange of Thailand Rich Asia Corporation Public Company Limited ("the Company") would like to report the information according to the
rates of interest rates on credit card from 18% to 16% per annum and personal loan from 28% to 25% per annum, effective from August 1, 2020 onward. However, a change of customer behavior to be more
, comparing to the same period of the previous year. Page 8 BLCP: Unit : Million Baht Quarter 2 Change Increase (Decrease) 2020 2019 Amount % Electricity revenue - Availability Payment (AP) - Energy Payment (EP
% growth of revenue from sales of house and condominium units and 71% increase in revenue from rental and services attributed to the rise of total revenue. 2Q19 Net profit at THB 192m, or 56% decline YoY
Date : February 27, 2017 Subject : The Explanation to SET concerning the operating result for the year 2017 more than 20% Attention : The Director and Manager of the Stock Exchange of Thailand For
Building Confidence in the Capital Market No. 139/2014 SEC notifies JAS to rectify 2013 and Q2/2014 financial statements Bangkok, September 25, 2014 – The SEC notified Jasmine International Plc. (JAS
proposed amendments. The SEC has therefore drafted the regulations and is now conducting this public hearing on the draft regulations , with the key points as summarized below: (1) To entitle